Weight Management Research
To learn more about obesity, overweight and ongoing clinical trials in the area, visit our Weight Management Research page.
Learn MoreThe main purpose of this study is to evaluate the safety and tolerability of the study drug known as LY3532226 in participants with obesity.
Have body weight below 150 kg (330 lbs) and body mass index (BMI) within 30 to 40 kilograms per meters squared (kg/m²)
Have stable body weight that has not changed more than 5% for 90 days prior to screening
Have a history of self-harm
Have a psychiatric disorder including major depressive disorder within 2 years of screening
Have abnormal stomach emptying or have had any form of stomach surgery
Intends to use weight loss medications while participating
Have diagnosed obesity from a hormone disorder, genetic inheritance, or syndrome
To learn more about obesity, overweight and ongoing clinical trials in the area, visit our Weight Management Research page.
Learn MoreLearn how Lilly is working with health care partners to improve diversity in our clinical studies.
Watch the VideoA clinical trial helps us learn if a new potential medicine or treatment works and how it works. Clinical trials are also called clinical research studies. To learn more about what to expect when taking part in a clinical trial, visit our Clinical Trial Information page.